Compound Medications for Personal Injury: A Complete Guide

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | May 8, 2024 | 12 min read

Compound medications play a growing role in personal injury treatment, from custom pain creams to specialized topical formulations. This guide explains what they are, why they're prescribed, how pricing works, and what attorneys and patients should know.

Compound Medications for Personal Injury: A Complete Guide

Compound medications are one of the most frequently misunderstood — and most frequently challenged — categories of pharmaceutical treatment in personal injury cases. Adjusters question their cost. Defense attorneys call them unnecessary. And patients often do not understand why their doctor prescribed a custom-made cream instead of something off the shelf at CVS.

The reality is more nuanced. Compounded medications serve a legitimate and often essential role in personal injury treatment, particularly for patients with complex pain profiles, medication sensitivities, or conditions that do not respond well to commercially available products. But the compounding space also has a history of pricing abuse that has made everyone — attorneys, insurers, and patients — understandably cautious.

This guide provides a clinical and practical overview of compound medications in the personal injury context: what they are, when they are appropriate, how pricing works, and how to defend their use at settlement.

[!KEY] Compound medications are legitimate pharmaceutical products that serve a specific clinical role in PI cases — but they require thorough clinical documentation to defend at settlement, where pricing challenges are routine.

What Are Compound Medications?

Compounding is the practice of combining, mixing, or altering pharmaceutical ingredients to create a medication tailored to an individual patient's needs. A compounding pharmacy prepares these medications based on a prescriber's specific instructions.

Unlike commercially manufactured drugs — which are mass-produced in standardized formulations by pharmaceutical companies — compounded medications are made one patient at a time, in specific strengths, combinations, and dosage forms that are not available as commercial products.

Common Examples in Personal Injury

The most frequently compounded medications in PI cases include:

Topical Pain Creams These are the workhorses of compounded PI medications. A typical compound pain cream might combine several active ingredients:

Ketamine (2-10%) — NMDA receptor antagonist for neuropathic pain
Gabapentin (6%) — nerve pain relief applied directly to the affected area
Cyclobenzaprine (2%) — muscle relaxant for localized spasm
Diclofenac (3%) — anti-inflammatory for joint and soft tissue pain
Lidocaine (5%) — local anesthetic for immediate pain relief

By combining these agents into a single topical formulation, the prescriber addresses multiple pain pathways simultaneously while minimizing systemic side effects. The patient applies the cream directly to the injury site rather than taking oral medications that affect the entire body.

Custom Strength Formulations Sometimes a patient needs a specific dose that is not commercially available. A pain management specialist might need Baclofen 5mg capsules when only 10mg and 20mg tablets are commercially manufactured, or a specific concentration of a topical that does not exist as a commercial product.

Alternative Dosage Forms A patient who cannot swallow pills due to jaw injuries from an accident might need medications reformulated as liquids, transdermal gels, or sublingual preparations.

Allergen-Free Preparations Patients with allergies to common inactive ingredients (dyes, fillers, preservatives, gluten, lactose) may need compounded alternatives that exclude those allergens.

Why Compound Medications Are Prescribed in PI Cases

Multi-Mechanism Pain Management

Personal injury patients often experience multiple types of pain simultaneously — nociceptive pain from tissue damage, neuropathic pain from nerve involvement, inflammatory pain from swelling, and muscular pain from spasm. A single commercial medication addresses one mechanism. A compound cream can address three or four at once.

This is particularly valuable for patients recovering from motor vehicle accidents, where injuries to muscles, joints, nerves, and soft tissue frequently coexist.

Reduced Systemic Side Effects

Oral pain medications circulate through the entire body, producing systemic effects — drowsiness from muscle relaxants, GI upset from anti-inflammatories, cognitive fog from nerve pain medications. Topical compounds deliver the active ingredients directly to the site of pain, achieving therapeutic concentrations locally while minimizing systemic exposure.

For patients who need to function — return to work, care for children, attend medical appointments — this reduction in systemic side effects can be the difference between adherence and abandonment of the treatment plan.

Failed Commercial Alternatives

Compounding is often a second-line or third-line approach. The prescriber has already tried commercially available options — oral NSAIDs, OTC topicals, prescription patches — and they have not provided adequate relief. The compound medication represents a clinical escalation, not a first choice, and the treatment record should reflect this progression.

[!KEY] When the treatment record documents the progression from oral NSAID to prescription patch to compounded topical, each step explains why the prior option was insufficient — that escalation narrative is the clinical story that defeats the "patient could have used a cheaper alternative" challenge and establishes the compound as a medically necessary, not optional, part of the treatment plan.

Specialized Clinical Protocols

Some pain management specialists and sports medicine physicians have developed evidence-based protocols using specific compound formulations. These protocols are tailored to injury types commonly seen in PI cases — whiplash, radiculopathy, CRPS, post-surgical pain — and have demonstrated clinical efficacy in their practices.

How Compound Medication Pricing Works

This is where the controversy lives. Compound medication pricing has historically been one of the most opaque and problematic areas in personal injury pharmacy costs.

Why Compounds Cost More Than Commercial Products

Several factors contribute to the higher cost of compounded medications:

Individual preparation — each prescription is made from scratch by a pharmacist, requiring labor, equipment, and quality control that mass manufacturing handles at scale
Ingredient sourcing — compounding pharmacies purchase pharmaceutical-grade raw ingredients, often in smaller quantities than commercial manufacturers, at higher per-unit costs
Quality assurance — reputable compounding pharmacies follow USP (United States Pharmacopeia) standards for sterility, potency, and beyond-use dating, which adds overhead
Specialized equipment — ointment mills, electronic balances, laminar flow hoods, and other compounding equipment represent significant capital investment
No insurance negotiation — commercial drug prices are beaten down by PBMs negotiating on behalf of insurers. Compounded medications typically fall outside these negotiation frameworks

The Pricing Problem in PI

The PI compounding space has experienced well-documented pricing abuse. Some compounding pharmacies and pharmacy lien companies have historically:

Charged dramatically inflated amounts for topical creams whose raw ingredients are inexpensive
Added high-cost ingredients (like brand-name ketamine or expensive peptides) primarily to increase the billable amount rather than for clinical necessity
Billed for compounding services at rates disconnected from the actual clinical value and overhead involved

This history of abuse means that adjusters and defense attorneys are primed to challenge any compounded medication as overpriced and unnecessary — even when the medication is clinically appropriate and reasonably priced.

What Reasonable Pricing Looks Like

Attorneys evaluating compound medication costs should understand the general pricing landscape and ask questions about the specific ingredients and their individual costs when charges appear disproportionate to the clinical need.

Defending Compound Medications at Settlement

When an adjuster challenges compounded medications, the challenge usually falls into one of four categories. Here is how to address each:

Challenge 1: "Compound Medications Are Experimental"

Response: Compounding is one of the oldest pharmaceutical practices, predating the modern pharmaceutical industry by centuries. The individual ingredients in most PI compound formulations are FDA-approved drugs being used within their established clinical indications — they are simply being combined and reformulated for topical delivery. The practice of compounding itself is regulated by state boards of pharmacy and, for certain categories, by the FDA under Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Challenge 2: "The Patient Could Have Used OTC Alternatives"

Response: The treatment record should document that commercially available alternatives were tried first or were clinically inappropriate for this patient. A clinical narrative explaining the progression from initial treatments to compound therapy — and why each prior treatment was insufficient — defeats this argument.

[!TIP] Prepare for the pricing challenge on compound medications at intake — request a complete ingredient itemization and clinical rationale from the PBA so you have the documentation ready before the adjuster questions it.

Challenge 3: "The Pricing Is Excessive"

Response: This is the most legitimate challenge and the one that requires the most preparation. Attorneys should be prepared to show:

The specific ingredients and their pharmaceutical-grade costs
The compounding labor and overhead components
Comparison to the cost of alternative treatments (which may be higher — oral medications with side effects requiring additional medications to manage, or more invasive procedures like nerve blocks)
Documentation from the PBA showing the pricing methodology

Challenge 4: "There Is No Clinical Evidence Supporting This Formulation"

Response: While specific multi-ingredient compound formulations may not have randomized controlled trial data (because they are individualized by definition), each ingredient has its own evidence base. A pharmacist-signed POGOS report can provide peer-reviewed citations for each active ingredient's mechanism of action and clinical efficacy for the patient's diagnosed conditions.

The Role of Compounding Pharmacies in the PBA Model

Within the LienScripts Pharmacy Benefit Administrator model, compound medications are handled with the same transparency and documentation standards as commercial medications:

Prescriber Authorization

All compound prescriptions must come from the patient's treating physician. The PBA does not initiate or suggest compounding — it facilitates access to what the prescriber has determined is clinically necessary.

Pricing Controls

Compound medication pricing through the PBA follows the same documented methodology as commercial medications, with complete itemization of each compounded prescription. This provides attorneys with the documentation they need to defend the charges at settlement.

Clinical Documentation

Every compounded medication dispensed is included in the patient's POGOS report, with a clinical narrative explaining:

Why the compound formulation was prescribed
The clinical rationale for each active ingredient
How the compound fits into the overall treatment plan
The relationship between the compound and the patient's documented injuries

Network Quality Standards

Compounding pharmacies within the network must meet quality standards for preparation, testing, and beyond-use dating. This ensures that the medications dispensed are clinically reliable and defensible.

What Patients Should Know

If your doctor has prescribed a compound medication as part of your personal injury treatment, here are the key things to understand:

It Is Not Unusual

Compounded medications are a standard part of pain management for many injury types. Your doctor prescribed a compound because they believe it will provide better relief, fewer side effects, or both compared to commercially available alternatives.

Cost Is Handled Through the Lien

If you are enrolled with a PBA like LienScripts, your compound medication is covered at $0 upfront cost — the same as any other prescription on your pharmacy benefit card. The cost is recovered from your settlement proceeds through the pharmacy lien, not from your pocket during treatment.

You Can Fill at Network Pharmacies

Many compound prescriptions can be filled at compounding pharmacies within the PBA's network. Your attorney or the PBA can help identify the nearest network compounding pharmacy. For more information about pharmacy network access, see our guide on how the pharmacy network works.

Follow the Prescribed Application Instructions

Compound topical medications work best when applied consistently as directed. Skipping applications creates treatment gaps in your medication timeline that can affect your case, just like missing any other prescribed treatment.

Key Takeaways

Compound medications are legitimate pharmaceutical products prepared by licensed pharmacists based on prescriber instructions. They are not experimental or fringe treatments.
They serve a specific clinical role in personal injury cases — multi-mechanism pain relief, reduced systemic side effects, and treatment options when commercial products have failed.
Pricing requires scrutiny because the compounding space has a history of abuse. Attorneys should ensure compound charges are backed by clinical documentation and a clear compounding rationale for each ingredient.
Clinical documentation is essential for defending compound medications at settlement. A pharmacist-signed clinical narrative explaining the rationale for each ingredient transforms a suspicious line item into a defensible treatment decision.

[!KEY] A POGOS report that explains each compounding ingredient individually — citing the documented injury, the clinical indication, and the reason a commercial alternative was not selected — converts a single compound prescription into multiple lines of evidence, each defending a separate aspect of the patient's injury profile.

Through a PBA model, compound medications are priced transparently, documented thoroughly, and covered at $0 upfront cost to the patient — the same as any other injury-related prescription.

Learn More

Related Resources

Frequently Asked Questions

Are compound medications covered by personal injury liens?

Compound medications prescribed by a treating physician are covered under pharmacy lien programs when clinically justified. Every compound on a lien should include a documented rationale for each active ingredient, explaining why a commercially available alternative was insufficient for the patient's specific injury presentation.

Can insurance companies deny compound medication claims?

Insurance adjusters frequently challenge compound medication costs as experimental or overpriced. The strongest defense is a pharmacist-signed clinical narrative — such as a POGOS report — that explains the medical necessity of each ingredient and how the formulation addresses the patient's specific pain mechanisms that commercial products could not adequately treat.

What makes compounding pharmacy personal injury liens defensible?

A defensible compounding pharmacy lien requires documented clinical rationale for each ingredient, evidence that commercial alternatives were tried or clinically inappropriate, and a pricing methodology with complete itemization. Reputable pharmacy benefit administrators provide this documentation automatically so attorneys can defend compound charges at settlement.

How do topical compound creams work for injury pain?

Topical compound creams combine multiple active ingredients — such as gabapentin, ketamine, diclofenac, and cyclobenzaprine — to address several pain pathways simultaneously. Applied directly to the injury site, they achieve therapeutic concentrations locally while minimizing the systemic side effects associated with oral medications.

When does a prescriber choose compounding over commercial medications?

Prescribers turn to compounding when commercial medications have failed, when a patient has allergies to inactive ingredients, when a specific dose or delivery form is unavailable commercially, or when a multi-mechanism approach to pain is clinically superior. Compounding is typically a second- or third-line option documented after standard treatments proved inadequate.